Managing Osteoporosis and Joint Damage in Patients with Rheumatoid Arthritis: An Overview
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Managing Osteoporosis and Joint Damage in Patients with Rheumatoid Arthritis: An Overview
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 10, Issue 6, Pages 1241
Publisher
MDPI AG
Online
2021-03-17
DOI
10.3390/jcm10061241
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
- (2020) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Views on glucocorticoid therapy in rheumatology: the age of convergence
- (2020) Frank Buttgereit Nature Reviews Rheumatology
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS—2020 UPDATE
- (2020) Pauline M. Camacho et al. Endocrine Practice
- Osteoporosis in patients with rheumatoid arthritis: an update in epidemiology, pathogenesis, and fracture prevention
- (2020) Hennie G Raterman et al. EXPERT OPINION ON PHARMACOTHERAPY
- Human dendritic cell-derived osteoclasts with high bone resorption capacity and T cell stimulation ability
- (2020) Manabu Narisawa et al. BONE
- RANKL as a therapeutic target of rheumatoid arthritis
- (2020) Sakae Tanaka et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Osteoporosis
- (2019) Juliet E Compston et al. LANCET
- Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial
- (2019) Tsutomu Takeuchi et al. ANNALS OF THE RHEUMATIC DISEASES
- Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study
- (2019) Josef S Smolen et al. LANCET
- Osteoporosis in Rheumatic Diseases: Anti-rheumatic Drugs and the Skeleton
- (2018) Alanna M. Dubrovsky et al. CALCIFIED TISSUE INTERNATIONAL
- Mechanisms and therapeutic targets for bone damage in rheumatoid arthritis, in particular the RANK-RANKL system
- (2018) Yoshiya Tanaka et al. CURRENT OPINION IN PHARMACOLOGY
- Therapeutic Mechanisms of Glucocorticoids
- (2018) Jolien Vandewalle et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Trends and Determinants of Osteoporosis Treatment and Screening in Patients With Rheumatoid Arthritis Compared to Osteoarthritis
- (2018) Gulsen Ozen et al. ARTHRITIS CARE & RESEARCH
- Rheumatoid arthritis
- (2018) Josef S. Smolen et al. Nature Reviews Disease Primers
- OUP accepted manuscript
- (2018) RHEUMATOLOGY
- Clinical immunity in bone and joints
- (2018) Yoshiya Tanaka JOURNAL OF BONE AND MINERAL METABOLISM
- Glucocorticoid-Induced Osteoporosis
- (2018) Lenore Buckley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathogenetic insights from the treatment of rheumatoid arthritis
- (2017) Iain B McInnes et al. LANCET
- RANKL: A therapeutic target for bone destruction in rheumatoid arthritis
- (2017) Sakae Tanaka et al. Modern Rheumatology
- Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis
- (2017) Peter C. Taylor et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
- (2017) Lenore Buckley et al. Arthritis & Rheumatology
- Osteoporosis treatment: recent developments and ongoing challenges
- (2017) Sundeep Khosla et al. Lancet Diabetes & Endocrinology
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
- (2017) Henry G Bone et al. Lancet Diabetes & Endocrinology
- Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis
- (2016) Shingo Nakayamada et al. BIODRUGS
- Rheumatoid arthritis
- (2016) Josef S Smolen et al. LANCET
- Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice
- (2016) Shintaro Hirata et al. Modern Rheumatology
- Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis
- (2016) Anca I. Catrina et al. Nature Reviews Rheumatology
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Postmenopausal Osteoporosis
- (2016) Dennis M. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Actions of Glucocorticoids in Cartilage and Bone During Health, Disease, and Steroid Therapy
- (2016) Kerstin Hartmann et al. PHYSIOLOGICAL REVIEWS
- Glucocorticoid-induced Osteoporosis
- (2016) Xena Whittier et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Postmenopausal osteoporosis
- (2016) Richard Eastell et al. Nature Reviews Disease Primers
- Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose–response study of AMG 162 (Denosumab) in patients withRheumatoId arthritis on methotrexate toValidate inhibitory effect on boneErosion (DRIVE)—a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial
- (2015) Tsutomu Takeuchi et al. ANNALS OF THE RHEUMATIC DISEASES
- Analysis of bone metabolism during early stage and clinical benefits of early intervention with alendronate in patients with systemic rheumatic diseases treated with high-dose glucocorticoid: Early DIagnosis and Treatment of OsteopoRosis in Japan (EDITOR-J) study
- (2015) Yoshiya Tanaka et al. JOURNAL OF BONE AND MINERAL METABOLISM
- A look behind the scenes: the risk and pathogenesis of primary osteoporosis
- (2015) Gretl Hendrickx et al. Nature Reviews Rheumatology
- Meta-Analysis of Tumor Necrosis Factor Inhibitors and Glucocorticoids on Bone Density in Rheumatoid Arthritis and Ankylosing Spondylitis Trials
- (2015) Stephanie Siu et al. ARTHRITIS CARE & RESEARCH
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osteitis and synovitis, but not bone erosion, is associated with proteoglycan loss and microstructure damage in the cartilage of patients with rheumatoid arthritis
- (2013) Barbara Herz et al. ANNALS OF THE RHEUMATIC DISEASES
- Janus kinase inhibitors in autoimmune diseases
- (2013) John J O'Shea et al. ANNALS OF THE RHEUMATIC DISEASES
- Differing effects of denosumab and alendronate on cortical and trabecular bone
- (2013) Roger M. Zebaze et al. BONE
- Arthritis and bone loss
- (2013) Arnd Kleyer et al. CURRENT OPINION IN RHEUMATOLOGY
- In vitro and in vivo analysis of a JAK inhibitor in rheumatoid arthritis
- (2012) Y Tanaka et al. ANNALS OF THE RHEUMATIC DISEASES
- Inflammatory bone loss: pathogenesis and therapeutic intervention
- (2012) Kurt Redlich et al. NATURE REVIEWS DRUG DISCOVERY
- Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment
- (2012) Georg Schett et al. Nature Reviews Rheumatology
- American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
- (2011) D. T. Felson et al. ANNALS OF THE RHEUMATIC DISEASES
- The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cells
- (2011) Keisuke Maeshima et al. ARTHRITIS AND RHEUMATISM
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- From bone biology to clinical outcome: state of the art and future perspectives
- (2010) G. Schett et al. ANNALS OF THE RHEUMATIC DISEASES
- 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
- (2010) Daniel Aletaha et al. ARTHRITIS AND RHEUMATISM
- Denosumab and bisphosphonates: Different mechanisms of action and effects
- (2010) Roland Baron et al. BONE
- Osteoimmunology and the effects of the immune system on bone
- (2009) Hiroshi Takayanagi Nature Reviews Rheumatology
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now